ticipate in screening for hypertension, with great interest. In the Netherlands, high blood pressure screening in the dental offi ce was also proposed, 20 years ago.
2 In a subsequent survey among 259 dentists, it was shown that if there was a fi nancial remuneration for the procedure, 40% of the respondents replied with a defi nite yes, while another 40% indicated that they might take part. Without fee, only 16% said they would defi nitely participate and 34% said they might.
3
The more recently graduated, the more willing the dentist was to participate in hypertension screening. The size of the practice also infl uenced the willingness to participate. Half of the dentists with a small practice (<500 patients) refused even when they were fi nancially compensated versus only 15% of those with a larger practice (>2,000 patients). 3 In view of these Dutch results, it is interesting to explore the current opinion of UK dentists on these issues, since they may affect the implementation of high blood pressure screening in the dental offi ce. H. S. Brand, E. C. I. Veerman ACTA industry-supported reviews on ethanol appear to have more favourable conclusions than the corresponding independent studies.
Besides the industry bias issue, there is a considerable amount of knowledge on mechanistic evidence and quantitative risk assessment that was only briefl y mentioned in the articles. While I agree that the risk of oral cancer from mouthwash use is diffi cult to quantify, 1 it is not completely impossible. We have recently shown that the use of alcoholcontaining mouthwashes may lead to acetaldehyde concentrations in the oral cavity of up to 105 µM, which exceeds levels that have been shown in vitro to form DNA adducts and cause sister chromatid exchanges. A twice-daily use of alcohol-containing mouthwashes leads to a low but quantifi able lifetime cancer risk of 3E-6. 10 The acetaldehyde burden may be increased by the cumulative exposure from a considerable number of other sources, which do not only include alcohol but also nutrition, fl avourings, tobacco, and environmental exposures. 
AN UNVIABLE APPROACH
Sir, I have followed the recent series of papers on the role of the dental therapist with interest. They describe attempts to follow a path trodden by the hygienists some years ago, when it was proposed to allow hygienists to set up independent practices. The laws allowing them to work without dentist supervisionand more importantly handle payments directly -were never passed. I do not remember any public debate as to why this never happened, but I suspect that when it was discovered that independent hygienists would charge the same to the patients as those working within a dental practice there was little incentive to allow full independence. The discussion of cost-effectiveness of therapists by the authors 1 goes over much the same ground. When the costs of the legally required nurse/chaperone are added to the low earning potential of a therapist working under NHS contract the whole concept of independent therapists becomes uneconomic. There is no way in which dentistry can be provided on the cheap in the UK by the equivalent of a third world 'barefoot doctor'; the regulations over how we deliver dentistry make this approach unviable. If cost control to government and patient is a priority why not ask the profession how it can be done? I am sure that many dentists would welcome a full and frank discussion and help to create a system of dental care appropriate to current conditions. S. W. White Shanklin 
FAMILIAR FORCEPS
Sir, I have been interested in the advert you published recently regarding a new line of dental forceps -'Physics Forceps from General Medical'. What fascinated me the most was the claim that these forceps were a revolutionary design using a beak and buffer principle. But are they? Now it is a fact that I have been involved with the dental world for several decades, and casting my mind back I cannot help but notice the similarity of this revolutionary design to the robust and reliable pelican noted for its use in Cromwell's day, and also in Hampton Court some years before that to deprive Good Queen Bess of yet another troublesome tooth. All more than 400 years ago.
The Physics Forceps also bear a very close resemblance to the well known and equally robust dental extractorthe 'Tooth Key' both of which instruments also use the by now familiar beak and bumper design. If you ask the curator of the BDA Museum nicely she will no doubt show you examples of both types.
Perhaps it is well that copyright only extends for 50 years after the designer's death. Or is it possible that somewhere in an English fi eld there lays the body of a well known tooth-puller to Lord Protector Cromwell? Maybe the marketplace tooth-puller feeling spiteful at being deprived of his 5% for the last four centuries, will arise from his grave at midnight, vampire-like, and pursue all those colleagues of mine who forgot to pay the 5% to original designer of these useful but rather outdated dental tools. 
SPIRALLING COSTS
Sir, we know that payment of a retention fee to the General Dental Council is mandatory. I did, however, enclose with it a note asking where the money was being used.
They have at least responded with a letter from a 'Process improvement Coordinator'. Thirty-eight percent of their 2008 expenditure was utilised on fi tness to practise activity. I do therefore wonder whether the other 62% was merely used to maintain an expensive offi ce! To make matters worse, I now have an annual retention fee notice from the General Medical Council for £410.00. When fi rst registering with the GMC, this was agreed to be a 'one-off payment'.
I do wonder where this is all spiralling. Perhaps you will publish my concerns, in order that colleagues may have the opportunity of joining with me in a response to these now non-professional bureaucracies.
B. Littler Chelmsford DOI: 10.1038/sj.bdj.2010.113
CAVALIER ATTITUDE
Sir, over the years I have prescribed Adcortyl in Orabase (triamcinolone acetonide 0.1%) for patients with recurrent oral ulceration. More recently it has been available as an 'over the counter' medicine.
I have been told by a number of patients that it is no longer available as it has been withdrawn. They could obtain no further information.
This prompted me to make enquiries on their behalf. I visited the DPF website where Adcortyl in Orabase is still listed.
I then contacted the manufacturers, Squibb Pharmaceuticals, who informed me that it had been withdrawn for 'commercial reasons'. When I asked how that
